Skip to main content
. 2023 Jul 12;20(8):3975–3986. doi: 10.1021/acs.molpharmaceut.3c00125

Table 5. Results of the DSC and FDM Analysesa,b.

formulation pH 3.7 pH 6.5
Tg, °C Tcr, °C Teu, °C Tc, °C Tg, °C Tcr, °C Teu, °C Tc, °C
M –31.1 –34.5 (C)     –35.8 –37.8 (C)    
    –23.8 (H)       –29.7 (H)    
S –33.5     –31.9 –36.9     –32.2
H –17.3     –14.6 –17.7     –14.9
M* –31.3 –34.2 (C)     –35.9 –37.4 (C)    
    –26.7 (H)       –28.4 (H)    
S* –33.4     –32 –37.0 -   –32.1
H* –17.8     –14.2 X
Bo   –18.9 –7.8   X
Mo –32.4 –35.4 (C) –7.9 –28.2 –35.6 –37.9 (C) –9.3 –28.2
    –26.3 (H)       –28.7 (H)    
    –20.2 (H)            
So –41.5 –23.3 (H) –8.3 –33.1 –38.2 –27.8 (H) –10.3 –32.1
Ho –33.5 –16.5 –7.8 –18.3 X
  –23.6        
Bo*     –12.6   X
      –7.9    
Mo* –32.0 –34.5 (C) –11.8 –29.2 –28.6 –37.9 (C) –13.6 –26.3
  –26.4 –22.6 (H) –8.3     –28.6 (H) –9.7  
So* –39.1   –14.9 –33.1 –38.3   –10.1 –32.1
      –8.7          
Ho* –29.5   –11.1 –18.2 X
  –23.4   –8.4    
Bo5     –9.8   X
      –8.6    
      0.9    
Bo10     –10.1   X
      –8.3    
      –2.5    
Bo30   –11.6 –8.0   X
      –5.9    
a

Tg: glass transition temperature of the maximally freeze-concentrated solution, Tcr: crystallization temperature, Teu: eutectic melting temperature, Tc: collapse temperature as determined by FDM, C: cooling, H: heating.

b

The table entries marked with ‘X’ indicate that measurements were not performed at that pH for the formulation under exam.